Insulet | PODD - Net Income


Insulet reported $95M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Abbott USD 928M 149M Jun/2026
Align Technology USD 108.29M 4.48M Jun/2026
AtriCure USD 8.96M 8.85M Jun/2026
Baxter International USD 126M 141M Jun/2026
Becton, Dickinson and Co. USD 377M 688M Jun/2026
Boston Scientific USD 907M 434M Jun/2026
Cardinal Health USD 398M 1000K Jun/2026
Cooper Companies USD -77.9M 208.7M Mar/2026
Dexcom USD 249.1M 49.6M Jun/2026
Edwards Lifesciences USD 241.9M 138.8M Jun/2026
Eli Lilly USD 7.1B 301M Jun/2026
Globus Medical USD 151.57M 27.27M Jun/2026
ICU Medical USD 19.09M 11.04M Jun/2026
Inogen USD -5.96M 373K Sep/2024
Insulet USD 95M 3.9M Jun/2026
Integra LifeSciences USD 4.48M 9.1M Jun/2026
J&J USD 5.53B 299M Jun/2026
Medtronic USD 1.24B 100M Mar/2026
Merit Medical Systems USD 41M 2.99M Mar/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Solventum Corp USD 92M 79M Jun/2026
Stryker USD 1.28B 531M Jun/2026
Tandem Diabetes Care USD -21.17M 775K Jun/2026
Teleflex USD 99.69M 107.85M Jun/2026
West Pharmaceutical Services USD 154M 15.2M Jun/2026
Zimmer Biomet Holdings USD 198.3M 39.8M Jun/2026